Physician profile
Sara Samaan
NPI 1295211035
$6,381.03
in general payments reported to CMS, 2019-2025
15 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $80.46 · 2022: $1,425 · 2023: $4,095 · 2024: $672 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,693 · Food and Beverage: $2,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,692.63 |
| Food and Beverage | $2,183.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,750.04 | 2022-2024 | Symplicity G3, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $571.30 | 2021-2023 | Watchman Flx, Watchman Access System |
| Biotronik INC. | $542.09 | 2022-2023 | Amvia Edge, Edora 8 Dr-T, Acticor 7 Vr-T Dx |
| Amgen INC. | $528.33 | 2022-2025 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $238.09 | 2022-2023 | Arcalyst |
| Genzyme Corporation | $148.10 | 2022-2023 | |
| Abiomed | $145.06 | 2024 | Impella |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2024 | Wainua |
| Novartis Pharmaceuticals Corporation | $58.61 | 2024 | |
| Inari Medical, INC. | $39.32 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Kiniksa Pharmaceuticals International, Plc | $34.60 | 2024 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $32.04 | 2023-2024 | |
| Cardiva Medical, INC. | $23.95 | 2023 | Cardiva Vascade 6/7f Vcs |
| Abbott Laboratories | $19.52 | 2023 | Mitraclip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Samaan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.